Moderna Inc (MRNA.O) said on Thursday that it is preparing to launch its experimental vaccine. He is one of the leading companies in the race to develop vaccines for the new Coronavirus. According to a Reuters report, the company has already received $ 1.1 billion for the supply. The company, based in Cambridge, Massachusetts, has entered into a settlement agreement with the US government and is negotiating with a WHO-led group to supply the vaccine. The vaccine is in the larger and further stages of human trials.
No clear date
Where the company has not given any clear time for releasing the data of these trials on Thursday. The company said with this that the initial data is expected in the coming week. This will depend on the number of infections in his study of 3,000 volunteers. Moderna does not currently have any approved products in the market. He is one of the few companies whose vaccine is in the final trial. In addition, vaccines of large companies such as Johnson & Johnson (JNJ.N) and Pfizer Inc (PFE.N) are in the late stages of trial.
ISRO issues instructions regarding first corona launching this year, next month
According to a Reuters report, the company’s chief executive officer Stéphane Bancel said that he believed that if he launched his Covid-19 vaccine, the year 2021 would be the most significant turning point in the history of Moderna. The company said that it is in talks with the World Health Organization-backed COVAX facility, which is negotiating an offer of a different level of price for the vaccine.